FRTX
Price
$0.91
Change
-$0.00 (-0.00%)
Updated
Feb 21 closing price
Capitalization
5.44M
3 days until earnings call
JBPHF
Price
$0.29
Change
-$0.07 (-19.44%)
Updated
Feb 20 closing price
Capitalization
199.83M
Ad is loading...

FRTX vs JBPHF

Header iconFRTX vs JBPHF Comparison
Open Charts FRTX vs JBPHFBanner chart's image
Fresh Tracks Therapeutics
Price$0.91
Change-$0.00 (-0.00%)
Volume$7.44K
Capitalization5.44M
Jacobio Pharmaceuticals Group
Price$0.29
Change-$0.07 (-19.44%)
Volume$5K
Capitalization199.83M
FRTX vs JBPHF Comparison Chart
Loading...
View a ticker or compare two or three
VS
FRTX vs. JBPHF commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FRTX is a Hold and JBPHF is a Buy.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (FRTX: $0.91 vs. JBPHF: $0.29)
Brand notoriety: FRTX and JBPHF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FRTX: 286% vs. JBPHF: 100%
Market capitalization -- FRTX: $5.44M vs. JBPHF: $199.83M
FRTX [@Biotechnology] is valued at $5.44M. JBPHF’s [@Biotechnology] market capitalization is $199.83M. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FRTX’s FA Score shows that 1 FA rating(s) are green whileJBPHF’s FA Score has 0 green FA rating(s).

  • FRTX’s FA Score: 1 green, 4 red.
  • JBPHF’s FA Score: 0 green, 5 red.
According to our system of comparison, FRTX is a better buy in the long-term than JBPHF.

Price Growth

FRTX (@Biotechnology) experienced а -2.15% price change this week, while JBPHF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

FRTX is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
JBPHF($200M) has a higher market cap than FRTX($5.44M). FRTX YTD gains are higher at: 22.973 vs. JBPHF (0.000).
FRTXJBPHFFRTX / JBPHF
Capitalization5.44M200M3%
EBITDA-5.65MN/A-
Gain YTD22.9730.000-
P/E RatioN/AN/A-
Revenue8.01MN/A-
Total Cash251KN/A-
Total Debt0N/A-
FUNDAMENTALS RATINGS
FRTX: Fundamental Ratings
FRTX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GEMCX19.98-0.01
-0.05%
Goldman Sachs Emerging Markets Eq C
EICVX17.77-0.10
-0.56%
EIC Value A
GBLFX37.96-0.24
-0.63%
American Funds Global Balanced F2
FSPCX91.69-0.80
-0.86%
Fidelity Select Insurance Port
BPLEX9.51-0.10
-1.04%
Boston Partners Long/Short Equity Inv

FRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, FRTX has been loosely correlated with LXRX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if FRTX jumps, then LXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FRTX
1D Price
Change %
FRTX100%
N/A
LXRX - FRTX
42%
Loosely correlated
-2.20%
DRTS - FRTX
38%
Loosely correlated
-6.62%
SLNO - FRTX
37%
Loosely correlated
-2.72%
CALC - FRTX
37%
Loosely correlated
-3.69%
IMVT - FRTX
33%
Poorly correlated
+4.01%
More

JBPHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, JBPHF has been closely correlated with RAPT. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if JBPHF jumps, then RAPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JBPHF
1D Price
Change %
JBPHF100%
N/A
RAPT - JBPHF
79%
Closely correlated
-0.79%
AXSM - JBPHF
32%
Poorly correlated
+6.70%
PYPD - JBPHF
23%
Poorly correlated
-0.33%
FRTX - JBPHF
22%
Poorly correlated
N/A
LXRX - JBPHF
21%
Poorly correlated
-2.20%
More